Market Closed - OTC Markets 03:59:40 2024-04-19 pm EDT 5-day change 1st Jan Change
1.26 USD -11.27% Intraday chart for Vapotherm, Inc. -21.25% +26.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Vapotherm, Inc. Enters into Amendment No. 7 to Loan and Security Agreement with SLR Investment Corp CI
Vapotherm, Inc. to Unveil Access365 Home Ventilation Solution at MEDTRADE CI
Vapotherm, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Vapotherm, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Vapotherm, Inc.(OTCPK:VAPO) dropped from S&P TMI Index CI
Vapotherm Says NYSE Suspends Its Shares' Trading Due to Non-Compliance With Market Capitalization Listing Rule MT
Top Premarket Decliners MT
Transcript : Vapotherm, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Vapotherm, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (VAPO) VAPOTHERM Posts Q3 Revenue $15.2M, vs. Street Est of $16.7M MT
Vapotherm, Inc. Revises Revenue Guidance for the Full Year 2023 CI
Vapotherm, Inc. Reiterates Revenue Guidance for the Full Year 2023 CI
Vapotherm, Inc. and its Chief Commercial Officer, Gregoire Ramade, Mutually Agreed to an Amicable Separation of Employment, Effective October 31, 2023 CI
Vapotherm Announces Presentation of an Investigator-Initiated Clinical Trial, 'High Flow Humidified Oxygen as an Early Intervention in Children with Acute Severe Asthma - a Feasibility Randomized Controlled Trial' at the European Respiratory Society International Congress 2023 CI
Vapotherm Shares Rise After Chief Executive Joseph Army Executes Stock Purchase MT
Insider Buy: Vapotherm MT
Insider Buy: Vapotherm MT
Insider Buy: Vapotherm MT
Insider Buy: Vapotherm MT
Transcript : Vapotherm, Inc., Q2 2023 Earnings Call, Aug 08, 2023
Vapotherm, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Earnings Flash (VAPO) VAPOTHERM Reports Q2 Revenue $16M, vs. Street Est of $17M MT
Vapotherm, Inc. Revises Earnings Guidance for Fiscal 2023 CI
Vapotherm, Inc.(NYSE:VAPO) dropped from Russell Microcap Index CI
Vapotherm, Inc.(NYSE:VAPO) dropped from Russell Microcap Growth Index CI
Chart Vapotherm, Inc.
More charts
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
More about the company